BriaCell Therapeutics Corp. Stock Nasdaq
Equities
BCTX
CA1079301091
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.27 USD | +0.44% | +5.09% | -61.20% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 35.51M |
---|---|---|---|---|---|
Net income 2024 * | -24M | Net income 2025 * | -36M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.6
x | P/E ratio 2025 * |
-1.59
x | Employees | 16 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 87.73% |
1 day | +0.44% | ||
1 week | +5.09% | ||
Current month | +4.61% | ||
1 month | -16.54% | ||
3 months | -45.17% | ||
6 months | -47.21% | ||
Current year | -61.20% |
Managers | Title | Age | Since |
---|---|---|---|
William Williams
CEO | Chief Executive Officer | 68 | 16-10-31 |
Gadi Levin
DFI | Director of Finance/CFO | 52 | 16-01-31 |
Chief Tech/Sci/R&D Officer | 53 | 21-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Martin Schmieg
BRD | Director/Board Member | 62 | 16-05-09 |
Marc Lustig
BRD | Director/Board Member | 51 | 21-08-30 |
Rebecca Taub
BRD | Director/Board Member | 71 | 18-03-06 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-06 | 2.27 | +0.44% | 11,965 |
24-05-03 | 2.26 | +0.89% | 28,649 |
24-05-02 | 2.24 | +6.16% | 22,347 |
24-05-01 | 2.11 | -2.76% | 13,936 |
24-04-30 | 2.17 | +0.46% | 43,038 |
Delayed Quote Nasdaq, May 06, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.15% | 106B | |
-1.08% | 104B | |
+6.00% | 23.25B | |
-11.55% | 22.5B | |
-7.19% | 18.7B | |
-37.08% | 17.95B | |
-9.91% | 16.99B | |
+7.55% | 14.26B | |
+40.04% | 12.76B |
- Stock Market
- Equities
- BCT Stock
- BCTX Stock